ARVNHealthcareBiotech — Protein Degraders·Sep 3, 2026·1 min read

ARVN: FY25 Deep Dive

Arvinas FY25 at $263M. NI $-81M; EPS $-1.28.

ARVN: FY25 Deep Dive

FY25 revenue $263M; OI $-115M; NI $-81M; EPS $-1.28.

Arvinas FY25 (Dec 31, 2025) at $263M revenue. OpInc $-115M; NI $-81M; EPS $-1.28. Biotech — Protein Degraders.

Related:ARVN

Want deeper analysis?

Ask drillr anything about ARVN — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free